Style de citation APA (7e éd.)

Li, J., Yue, H., Li, W., Zhu, G., Zhu, T., Chen, R., & Lu, X. (2021). Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression. BMC.

Style de citation Chicago (17e éd.)

Li, Jun, Huiran Yue, Wenzhi Li, Guohua Zhu, Tingting Zhu, Ruifang Chen, et Xin Lu. Bevacizumab Confers Significant Improvements in Survival for Ovarian Cancer Patients with Low MiR-25 Expression and High MiR-142 Expression. BMC, 2021.

Style de citation MLA (8e éd.)

Li, Jun, et al. Bevacizumab Confers Significant Improvements in Survival for Ovarian Cancer Patients with Low MiR-25 Expression and High MiR-142 Expression. BMC, 2021.